A mitochondrial DNA mutation influences the apoptotic effect of statins on prostate cancer

Qian Sun; Rebecca S. Arnold; Carrie Q Sun; John A Petros

doi:10.1002/pros.23089

journal article Sep 18, 2015

A mitochondrial DNA mutation influences the apoptotic effect of statins on prostate cancer

Qian Sun

Rebecca S. Arnold Carrie Q Sun John A Petros

The Prostate Vol. 75 No. 16 pp. 1916-1925 · Wiley

View at Publisher Save 10.1002/pros.23089

Topics

No keywords indexed for this article. Browse by subject →

References

20

[1]

Chatterjee "Mitochondrial DNA mutations in human cancer" Oncogene (2006) 10.1038/sj.onc.1209604

[2]

Taylor "Mitochondrial DNA mutations in human disease" Nat Rev Genet (2005) 10.1038/nrg1606

[3]

Arnold "An inherited heteroplasmic mutation in mitochondrial gene COI in a patient with prostate cancer alters reactive oxygen, reactive nitrogen, and proliferation" Biomed Res Int (2013) 10.1155/2013/239257

[4]

Papadopoulos "Statins and prostate cancer: Molecular and clinical aspects" Eur J Cancer (2011) 10.1016/j.ejca.2011.01.005

[5]

Kochuparambil "Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression" J Pharmacol Exp Ther (2011) 10.1124/jpet.110.174870

[6]

Platz "Statin drug use is not associated with prostate cancer risk in men who are regularly screened" J Urol (2014) 10.1016/j.juro.2014.01.095

[7]

Yu "Use of statins and the risk of death in patients with prostate cancer" J Clin Oncol (2014) 10.1200/jco.2013.49.4757

[8]

Park "Simvastatin induces apoptosis in castrate resistant prostate cancer cells by deregulating nuclear factor kB pathway" J Urol (2013) 10.1016/j.juro.2012.10.030

[9]

Petros "MtDNA mutations increase tumorigenicity in prostate cancer" Proc Natl Acad Sci USA (2005) 10.1073/pnas.0408894102

[10]

Hammond-McKibben "A high-capacity quantitative mouse model of drug-mediated immunosuppression based on rejection of an allogeneic subcutaneous tumor" J Pharmacol Exp Ther (2001) 10.1016/s0022-3565(24)29644-0

[11]

Booker "North American white mitochondrial haplogroups in prostate and renal cancer" J Urol (2006) 10.1016/s0022-5347(05)00163-1

[12]

Chen "Mitochondrial mutagenesis and oxidative stress in human prostate cancer" J Environ Sci Health C Environ Carcinog Ecotoxicol Rev (2004) 10.1081/gnc-120037931

[13]

Gómez-Zaera "Identification of somatic and germline mitochondrial DNA sequence variants in prostate cancer patients" Mutat Res (2006) 10.1016/j.mrfmmm.2005.10.012

[14]

Ray "Sequence variation in the mitochondrial gene cytochrome c oxidase subunit I and prostate cancer in African American men" Prostate (2009) 10.1002/pros.20943

[15]

Yu "Effect of mtDNA mutation on tumor malignant degree in patients with prostate cancer" Aging Male (2010) 10.3109/13685530903536668

[16]

Platz "Statin drugs and risk of advanced prostate cancer" J Natl Cancer Inst (2006) 10.1093/jnci/djj499

[17]

Jakobisiak M Golab J 2010 30 102 135 10.1002/med.20162

[18]

Hoque "Statin induces apoptosis and cell growth arrest in prostate cancer cells" Cancer Epidemiol Biomarkers Prev (2008) 10.1158/1055-9965.epi-07-0531

[19]

Goc "Simultaneous modulation of the intrinsic and extrinsic pathways by simvastatin in mediating prostate cancer cell apoptosis" BMC Cancer (2012) 10.1186/1471-2407-12-409

[20]

Zielinski "Targeting the apoptosis pathway in prostate cancer" Cancer J (2013) 10.1097/ppo.0b013e3182801cf7

Metrics

22

Citations

20

References

Details

Published: Sep 18, 2015
Vol/Issue: 75(16)
Pages: 1916-1925
License: View

Authors

Q

Qian Sun

Department of Urology; Emory University School of Medicine; Atlanta Georgia

R

Rebecca S. Arnold

Department of Urology; Emory University School of Medicine; Atlanta Georgia; Emory University Winship Cancer Institute; Atlanta Georgia

C

Carrie Q Sun

Department of Urology; Emory University School of Medicine; Atlanta Georgia

J

John A Petros

Department of Urology; Emory University School of Medicine; Atlanta Georgia; Emory University Winship Cancer Institute; Atlanta Georgia; The Atlanta VA Medical Center; Decatur Georgia; Emory University Winship Cancer Institute; Atlanta Georgia; Department of Pathology; Emory University School of Medicine; Atlanta Georgia. Department of Hematology and Medical Oncology; Emory University School of Medicine; Atlanta Georgia

Funding

National Institutes of Health Award: CA098912

Cite This Article

Qian Sun, Rebecca S. Arnold, Carrie Q Sun, et al. (2015). A mitochondrial DNA mutation influences the apoptotic effect of statins on prostate cancer. The Prostate, 75(16), 1916-1925. https://doi.org/10.1002/pros.23089

A mitochondrial DNA mutation influences the apoptotic effect of statins on prostate cancer

You May Also Like